Home  |  Contact

UniProtKB/Swiss-Prot P68871: Variant p.Leu115Pro

Hemoglobin subunit beta
Gene: HBB
Variant information

Variant position:  115
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Leucine (L) to Proline (P) at position 115 (L115P, p.Leu115Pro).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Similar physico-chemical property. Both residues are medium size and hydrophobic.
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -3
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In B-THAL; Durham-N.C./Brescia.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  115
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  147
The length of the canonical sequence.

Location on the sequence:   DKLHVDPENFRLLGNVLVCV  L AHHFGKEFTPPVQAAYQKVV
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 2 – 147 Hemoglobin subunit beta
Site 96 – 96 Not glycated
Glycosylation 121 – 121 N-linked (Glc) (glycation) lysine
Helix 102 – 119


Literature citations

Electrophoretically silent, very unstable, thalassemic mutation at codon 114 of beta globin (hemoglobin Durham-N.C.) detected by cDNA sequencing of mRNA, from a Russian women.
Kutlar F.; Abboud M.; Leithner C.; Holley L.; Brisco J.; Kutlar A.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT DURHAM-N.C. PRO-115;

A novel beta-globin structural mutant, Hb Brescia (beta 114 Leu-Pro), causing a severe beta-thalassemia intermedia phenotype.
Murru S.; Poddie D.; Sciarratta G.V.; Agosti S.; Baffico M.; Melevendi C.; Pirastu M.; Cao A.;
Hum. Mutat. 1:124-128(1992)
Cited for: VARIANT DURHAM-N.C. PRO-115;

A novel beta-globin mutation, beta Durham-NC [beta 114 Leu-->Pro], produces a dominant thalassemia-like phenotype.
de Castro C.M.; Devlin B.; Fleenor D.E.; Lee M.E.; Kaufman R.E.;
Blood 83:1109-1116(1994)
Cited for: VARIANT DURHAM-N.C. PRO-115;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.